New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.
The Brighterside of News on MSN4h
Scientists develop microcellular drones to deliver cancer-killing drugsLung cancer is one of the leading causes of cancer mortality worldwide. Non-small cell lung cancer (NSCLC) accounts for about ...
A new University of Kentucky Markey Cancer Center study provides important insights for future clinical trials in treating ...
The following is a summary of “Transcriptional regulatory network analysis identifies GRN as a key regulator bridging chemotherapy and immunotherapy response in small cell lung cancer,” published in ...
EXCLUSIVE: Retired David Mather was dealt a shocking blow when told his tiredness was stage-IV lung cancer - now a new UK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback